CLINICAL_TRIALS
trial_result
· 2013-06-06
Clinical Trial Update: Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating Bortezomib in patients with advanced or metastatic sarcoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED